AstraZeneca's David Brennan - CEO Pay
David Brennan - AstraZeneca
Total Compensation: $4.3M
2007 Revenue: $29.55B
2006 Revenue: $26.47B
Change: 11.6%
Details: Brennan made 2.15 million pounds ($4.3 million) in 2007, about $2 million of that as base salary and the rest variable compensation. Though his base was set at 5.5 percent higher in 2007 than 2006, his total package dropped by 19 percent because of smaller bonus and decreased reimbursements for relocation expenses. Overall, his pay fell 19%.
AstraZeneca News:
AstraZeneca's CEO sees 19% pay cut
Analyst: AZ "worst performer" in pharma
AstraZeneca lays out road map for recovery
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: